Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 3/20 | 0.43 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6309089 | 0.75 | CSNK2A1 (0.39) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL824416 | 0.72 | CSNK2A1 (0.55) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL22857644 | 0.69 | ALDH1A1 (0.40) | ALDH1A1PDPK1PARP1CHEK1ABL1 | |
| SCHEMBL15800772 | 0.68 | PARP1 (0.46) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL22566981 | 0.68 | CSNK2A1 (0.41) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL12846132 | 0.66 | PDPK1 (0.34) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL6956986 | 0.65 | MAPT (0.46) | MEN1KMT2AALDH1A1PARP1TDP1 | |
| SCHEMBL6956994 | 0.65 | MAPT (0.41) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL1967365 | 0.65 | PARP1 (0.39) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B | |
| SCHEMBL12573417 | 0.65 | CSNK2A1 (0.39) | CSNK2A1CSNK2A2MEN1RAB9ACSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11552266-B2 | Electrodes for electronic devices comprising an organic semiconducting layer | FLEXENABLE LIMITED (GB) | 2023-01-10 | — | — | US | disclosed |
| WO-2022165198-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2022-08-04 | — | — | WO | disclosed |
| US-20200274086-A1 | ELECTRODES FOR ELECTRONIC DEVICES COMPRISING AN ORGANIC SEMICONDUCTING LAYER | FLEXENABLE LIMITED (GB) | 2020-08-27 | — | — | US | disclosed |
| WO-2019052978-A1 | ELECTRODES FOR ELECTRONIC DEVICES COMPRISING AN ORGANIC SEMICONDUCTING LAYER | MERCK PATENT GMBH (DE) | 2019-03-21 | — | — | WO | disclosed |
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| EP-3279997-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY | Asahi Kasei Kabushiki Kaisha (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-8878165-B2 | Electrode treatment process for organic electronic devices | MERCK PATENT GMBH (DE) | 2014-11-04 | — | — | US | disclosed |
| US-20120319097-A1 | ELECTRODE TREATMENT PROCESS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-12-20 | — | — | US | disclosed |
| WO-2011103952-A1 | ELECTRODE TREATMENT PROCESS FOR ORGANIC ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-09-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | CSNK2A1 1101/4885CSNK2A2 1165/4885MEN1 1058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.